Mark E. Saad - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: AXSM on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Mark E. Saad - trading volume in the past year for Axsome Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-9.13K	100%	$125.07	-$1.14M
Net	-9.13K	-100%		-$1.14M

Holdings reported by Mark E. Saad for Axsome Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	10K	$1.25M	$125.07	Sep 5, 2025	Direct
Common Stock	300	$35.1K	$116.99	Sep 5, 2025	Indirect
Stock Option (Right to Buy)	0	$5.23K	$3.50	Sep 5, 2025	Direct	Common Stock
Restricted Stock Units	1.43K			Jun 6, 2025	Direct	Common Stock

Transactions reported by Mark E. Saad for Axsome Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.